Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab improves survival in advanced melanoma and can induce immune-mediated tumor vasculopathy. Besides promoting angiogenesis, vascular endothelial growth factor (VEGF) suppresses dendritic cell maturation and modulates lymphocyte endothelial trafficking. This study investigated the combinatio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Immunol Res
Päätekijät: Hodi, F. Stephen, Lawrence, Donald, Lezcano, Cecilia, Wu, Xinqi, Zhou, Jun, Sasada, Tetsuro, Zeng, Wanyong, Giobbie-Hurder, Anita, Atkins, Michael B., Ibrahim, Nageatte, Friedlander, Philip, Flaherty, Keith T., Murphy, George F., Rodig, Scott, Velazquez, Elsa F., Mihm, Martin C., Russell, Sara, Dipiro, Pamela, Yap, Jeffrey T., Ramaiya, Nikhil, Van den Abbeele, Annick D., Gargano, Maria, McDermott, David
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4306338/
https://ncbi.nlm.nih.gov/pubmed/24838938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0053
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia